SAM
CO

Silphium Asset Management’s Global Cord Blood Corporation CO Stock Holding History

Silphium Asset Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-202,801
Closed -$1.42M – 134
2018
Q3 		$1.42M Sell
202,801
-182,455
-47% -$1.37M 0.4% 46
2018
Q2 		$3.66M Sell
385,256
-274,911
-42% -$2.63M 1.15% 29
2018
Q1 		$6.73M Buy
+660,167
New +$6.74M 3.66% 11

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Silphium Asset Management's CO Position: Q4 2018 in Review

Silphium Asset Management sold out of Global Cord Blood Corporation (CO) in Q4 2018, closing a stake of 202,801 shares — an estimated $1.42M sold.

Silphium Asset Management first reported a position in CO in Q1 2018 and held it in 3 quarters. The position peaked at $6.73M in Q1 2018. 40 funds tracked by Wall St. Rank hold CO as of Q4 2018.

  • Silphium Asset Management reported no remaining Global Cord Blood Corporation position as of Q4 2018 after selling out during the quarter.
  • Silphium Asset Management sold 202,801 Global Cord Blood Corporation shares in Q4 2018, an estimated $1.42M.
  • Silphium Asset Management first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 3 quarters.
  • Silphium Asset Management's Global Cord Blood Corporation position peaked at $6.73M in Q1 2018.
  • 40 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2018.

Based on Silphium Asset Management's 13F filing for Q4 2018, filed 30 Jan 2025.